Cetuximab



Indications and Reactions:

Role Indications Reactions
Primary
Non-small Cell Lung Cancer 29.0%
Head And Neck Cancer 19.7%
Gastrooesophageal Cancer 8.1%
Colorectal Cancer Metastatic 8.0%
Prophylaxis 5.3%
Colorectal Cancer 4.8%
Colon Cancer 4.0%
Oesophageal Carcinoma 3.4%
Squamous Cell Carcinoma 3.1%
Hypertension 2.1%
Pain 2.0%
Nausea 1.8%
Neoplasm Malignant 1.6%
Pancreatic Carcinoma 1.4%
Premedication 1.3%
Gastric Cancer 1.1%
Non-small Cell Lung Cancer Metastatic 1.0%
Breast Cancer Metastatic 0.9%
Rash 0.7%
Constipation 0.7%
Vomiting 13.7%
Pulmonary Embolism 10.8%
Thrombocytopenia 9.6%
Pyrexia 6.3%
Sepsis 5.3%
Pneumonia 5.1%
Deep Vein Thrombosis 5.1%
Neutropenia 4.9%
Weight Decreased 4.3%
Syncope 4.0%
Mucosal Inflammation 3.9%
Dyspnoea 3.8%
Decreased Appetite 3.5%
Anaemia 3.2%
Stomatitis 3.0%
Dehydration 2.8%
Dysphagia 2.8%
Thrombosis 2.8%
Febrile Neutropenia 2.6%
Respiratory Failure 2.6%
Secondary
Non-small Cell Lung Cancer 18.6%
Colorectal Cancer Metastatic 15.4%
Head And Neck Cancer 11.5%
Prophylaxis 11.4%
Drug Use For Unknown Indication 6.9%
Colorectal Cancer 6.0%
Colon Cancer 5.8%
Product Used For Unknown Indication 3.7%
Pain 3.5%
Hypertension 2.3%
Nausea 2.1%
Rectal Cancer 1.9%
Squamous Cell Carcinoma 1.7%
Premedication 1.5%
Squamous Cell Carcinoma Of Head And Neck 1.3%
Pancreatic Carcinoma 1.3%
Colon Cancer Metastatic 1.3%
Metastatic Gastric Cancer 1.2%
Gastric Cancer 1.2%
Metastases To Liver 1.2%
Vomiting 14.5%
Pneumonia 10.4%
Pulmonary Embolism 8.9%
Pyrexia 7.0%
Weight Decreased 6.1%
Thrombocytopenia 5.4%
Sepsis 4.9%
Death 4.3%
General Physical Health Deterioration 3.8%
White Blood Cell Count Decreased 3.7%
Dyspnoea 3.6%
Neutropenia 3.5%
Diarrhoea 3.4%
Septic Shock 3.3%
Nausea 3.1%
Pain 3.0%
Dehydration 2.9%
Renal Failure Acute 2.8%
Urinary Tract Infection 2.8%
Hypomagnesaemia 2.7%
Concomitant
Drug Use For Unknown Indication 15.0%
Colorectal Cancer 13.1%
Colorectal Cancer Metastatic 9.6%
Product Used For Unknown Indication 7.6%
Non-small Cell Lung Cancer 7.2%
Colon Cancer 5.5%
Colon Cancer Metastatic 5.5%
Adenocarcinoma Pancreas 5.3%
Prophylaxis 5.2%
Adenocarcinoma 3.3%
Hypertension 3.1%
Rectal Cancer 2.9%
Nausea 2.8%
Pancreatic Carcinoma Non-resectable 2.4%
Squamous Cell Carcinoma 2.4%
Cancer Pain 2.3%
Chemotherapy 2.3%
Metastatic Gastric Cancer 1.6%
Pain 1.6%
Rectal Cancer Metastatic 1.3%
Vomiting 17.0%
Pneumatosis Intestinalis 7.1%
Portal Vein Thrombosis 7.1%
Disease Progression 6.3%
Gastrointestinal Ulcer 6.3%
Thrombocytopenia 5.4%
Dehydration 4.5%
Nausea 4.5%
Osteonecrosis 4.5%
Device Occlusion 3.6%
Gouty Arthritis 3.6%
Headache 3.6%
Neoplasm Malignant 3.6%
Off Label Use 3.6%
Pneumonia 3.6%
Pneumonitis 3.6%
Pruritus 3.6%
Varices Oesophageal 3.6%
Haemolytic Uraemic Syndrome 2.7%
Hypersensitivity 2.7%
Interacting
Myocardial Ischaemia 100.0%
Myalgia 100.0%